ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2018

Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study.

S de Vos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.